0000000000277080

AUTHOR

Hanife Bahsi

showing 4 related works from this author

The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-κB) pathway by targeting RelA/p65.

2015

Infection with human cytomegalovirus (HCMV) is a serious medical problem, particularly in immunocompromised individuals and neonates. The success of standard antiviral therapy is hampered by low drug compatibility and induction of viral resistance. A novel strategy is based on the exploitation of cell-directed signaling inhibitors. The broad antiinfective drug artesunate (ART) offers additional therapeutic options such as oral bioavailability and low levels of toxic side-effects. Here, novel ART-derived compounds including dimers and trimers were synthesized showing further improvements over the parental drug. Antiviral activity and mechanistic aspects were determined leading to the followi…

DrugHuman cytomegalovirusTranscriptional Activationmedia_common.quotation_subjectTranscription Factor RelAArtesunateCytomegalovirusPharmacologyCREBAntiviral Agentschemistry.chemical_compoundVirologyDrug Resistance ViralmedicineHumansCyclic AMP Response Element-Binding ProteinHerpesviridaemedia_commonPharmacologybiologyHEK 293 cellsNF-kappa BTranscription Factor RelANF-κBmedicine.diseaseIn vitroArtemisininsUp-RegulationHEK293 CellschemistryMutationbiology.proteinSignal transductionSignal TransductionAntiviral research
researchProduct

New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane…

2015

Abstract In our ongoing search for highly active hybrid molecules exceeding their parent compounds in anticancer, antimalaria as well as antiviral activity and being an alternative to the standard drugs, we present the synthesis and biological investigations of 2nd generation 1,2,4-trioxane-ferrocene hybrids. In vitro tests against the CCRF-CEM leukemia cell line revealed di-1,2,4-trioxane-ferrocene hybrid 7 as the most active compound (IC50 of 0.01 μM). Regarding the activity against the multidrug resistant subline CEM/ADR5000, 1,2,4-trioxane-ferrocene hybrid 5 showed a remarkable activity (IC50 of 0.53 μM). Contrary to the antimalaria activity of hybrids 4–8 against Plasmodium falciparum …

Human cytomegalovirusMetallocenesPlasmodium falciparumHeterocyclic Compounds 4 or More RingsInhibitory Concentration 50chemistry.chemical_compoundHeterocyclic CompoundsCell Line TumorDrug DiscoverymedicineHumansFerrous CompoundsArtemisininIC50HybridPharmacologyLeukemiabiologyOrganic ChemistryPlasmodium falciparumGeneral Medicinebiology.organism_classificationmedicine.diseaseVirologyArtemisininsDrug Resistance MultipleMultiple drug resistanceBiochemistryFerrocenechemistry124-Trioxanemedicine.drugEuropean Journal of Medicinal Chemistry
researchProduct

CCDC 994084: Experimental Crystal Structure Determination

2015

Related Article: Christoph Reiter, Tony Fröhlich, Maen Zeino, Manfred Marschall, Hanife Bahsi, Maria Leidenberger, Oliver Friedrich, Barbara Kappes, Frank Hampel, Thomas Efferth, Svetlana B. Tsogoeva|2015|Eur.J.Med.Chem.|97|164|doi:10.1016/j.ejmech.2015.04.053

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters1-(((369-trimethyldecahydro-12H-312-epoxypyrano[43-j][12]benzodioxepin-10-yl)oxy)carbonyl)ferroceneExperimental 3D Coordinates
researchProduct

CCDC 994085: Experimental Crystal Structure Determination

2015

Related Article: Christoph Reiter, Tony Fröhlich, Maen Zeino, Manfred Marschall, Hanife Bahsi, Maria Leidenberger, Oliver Friedrich, Barbara Kappes, Frank Hampel, Thomas Efferth, Svetlana B. Tsogoeva|2015|Eur.J.Med.Chem.|97|164|doi:10.1016/j.ejmech.2015.04.053

Space GroupCrystallography11'-bis(((369-trimethyldecahydro-12H-312-epoxypyrano[43-j][12]benzodioxepin-10-yl)oxy)carbonyl)ferrocene dichloromethane solvateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct